Drug, Supplement Industries Need Formal But Timely Guidance - Stakeholders
This article was originally published in The Tan Sheet
Executive Summary
Food and drug industry stakeholders suggest FDA clarify regulatory expectations and justify requirements through written and finalized formal guidance rather than through speeches and other informal communications